Imatinib treatment duration is related to decreased estimated glomerular filtration rate in chronic myeloid leukemia patients

Acute Renal Failure under Dasatinib Therapy

(2010) Sultan Ozkurt et al.   RENAL FAILURE

Defining Incident Chronic Kidney Disease in the Research Setting: The ARIC Study

(2009) L. D. Bash et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Dysregulation of bone remodeling by imatinib mesylate

(2009) K. Vandyke et al.   BLOOD

Glomerular filtration rate measurement and prediction equations

(2009) Ariana Aguiar Soares et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

(2009) Michele Baccarani et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumor lysis syndrome after starting treatment with Gleevec in a patient with chronic myelogenous leukemia

(2009) A. Al-Kali et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

(2009) A Hochhaus et al.   LEUKEMIA

Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis

(2009) Arturo Vega-Ruiz et al.   LEUKEMIA RESEARCH

Renal failure associated with tyrosine kinase inhibitors—Case report and review of the literature

(2009) Anat Gafter-Gvili et al.   LEUKEMIA RESEARCH

Renal toxicity of targeted therapies

(2009) Ronan J. Kelly et al.   Targeted Oncology

Resistant Hypertension: Diagnosis, Evaluation, and Treatment

(2008) David A. Calhoun et al.   CIRCULATION

An evaluation of the cardiotoxicity of imatinib mesylate

(2008) Antonio Luiz Ribeiro et al.   LEUKEMIA RESEARCH

IFN-α induces barrier destabilization and apoptosis in renal proximal tubular epithelium

(2007) Judith Lechner et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY